Articles

Lilly loses bid to end revived Zyprexa U.K. patent case

The High Court in London on Tuesday denied Lilly’s request for a judgment without trial against Neopharma Ltd., the closely held company that has European marketing rights for the generic version of the drug known chemically as olanzapine.

Read More

IU Health loses CFO to larger hospital system

Marvin Pember, 58, is taking a new job near Philadelphia as the president of the acute care division of Universal Health Services Inc., a publicly traded company with 22 acute hospitals and numerous behavioral health centers spread from coast to coast.

Read More

Quarterly lobbying bill adds up to $2.5M for Lilly

Indianapolis-based Eli Lilly and Co. raised its spending 8 percent from the $2.3 million that it spent in the first quarter of last year. The drugmaker also spent 70 percent more than the $1.5 million recorded in the final quarter of 2010, according to lobbying reports filed with the House of Representatives.

Read More
Wellpoint

WellPoint spent $1.5M lobbying feds in first quarter

WellPoint Inc., the nation's largest health insurer based on membership, spent about $1.5 million lobbying the federal government in the first quarter, as the health care overhaul debuted a new restriction that concerned managed care companies.

Read More

Q&A

Jim Alender has been CEO of Howard Regional Health System in Kokomo since 1997. He recently negotiated a letter of intent to merge the hospital with Indianapolis-based Indiana University Health. He spoke about the major factors that led to that decision, and the benefits he hopes to come from it. The deal, which still requires approval from Howard County officials, could close before the end of this year.

Read More

How to sell Martinsville to MDs

Help with physician recruitment is a big factor pushing small-city hospitals into the arms of Indianapolis’ four major hospital systems. So how do the big boys entice doctors to the small towns?

Read More

Zyprexa appeal rejected by Supreme Court

The U.S. Supreme Court has refused to revive a bid to press a $6.8 billion class-action suit against Eli Lilly and Co. over the marketing of Zyprexa, the company’s schizophrenia treatment.

Read More

Planned Parenthood defunding blocked

Planned Parenthood of Indiana expects to resume offering services to Medicaid patients following a judge's ruling that the state is not allowed to cut off the organization's public funding for general health services solely because it also provides abortions.

Read More

WellPoint goes online to educate about ER use

Health insurer WellPoint Inc. has enlisted Google Maps for new websites that help patients think twice before they visit an emergency room for care that a less-expensive retail health clinic could handle.

Read More

Planned Parenthood stops seeing Medicaid patients

Planned Parenthood of Indiana is no longer seeing Medicaid patients because a federal judge hasn't ruled yet on its attempt to block a new Indiana law cutting funding for certain abortion providers, officials said Monday.

Read More

Survey: Hospitals still rewarding docs for volume

The latest physician recruitment survey from Texas-based Merritt Hawkins shows three-quarters of all physician searches include a performance bonus for the doctor. Fewer than 10 percent of those bonuses are tied to something other than volume of procedures.

Read More

Troubled economy fueling hospital deals

Battered by stagnant population growth and blue-collar job loss, Howard Regional Health is merging with Indiana University Health—a deal that reflects the challenges faced by hospitals in Indiana’s outlying cities.

Read More

IU Health strikes deal with Central Indiana Cancer Centers

Central Indiana Cancer Centers sold its five facilities to IU Health and transferred its 150 employees to the Indianapolis-based hospital system. The 16 physicians in the practice will remain independent, but they have signed a service agreement with IU Health that pulls the two entities into a tight embrace.

Read More